Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PAPD5 inhibitors(Non canonical RNA polymerase PAPD5 inhibitors), PAPD7 inhibitors(terminal nucleotidyltransferase 4A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 2 | FR | 14 Apr 2022 | |
Hepatitis B, Chronic | Phase 2 | KR | 14 Apr 2022 | |
Hepatitis B, Chronic | Phase 2 | TH | 14 Apr 2022 | |
Hepatitis B, Chronic | Phase 2 | GB | 14 Apr 2022 | |
Hepatitis B, Chronic | Phase 2 | CA | 14 Apr 2022 | |
Hepatitis B, Chronic | Phase 2 | IT | 14 Apr 2022 |